Developing Compelling Global Health Policy Narratives and Supporting Evidence

As a part of its global therapeutic area (TA) health policy initiatives, a leading biopharma company needed a new and improved narrative and evidence deck to impress upon policymakers and other critical stakeholders the importance of timely diagnosis and treatment of a specific disease. The materials were structured in three sections:

  1. Making the case for change for policy makers
  2. Giving reasons to believe effective policy solutions are available
  3. Issuing a call to action by policy makers

BTG delivered a senior health policy consultant to analyze the current research and materials to better understand the burden and impact of the disease. The consultant then created a TA-specific health policy narrative for both U.S. and ex-U.S. markets, developed a one-page leave-behind tailored to each market, and built an external evidence deck for presentation at regional franchise meetings.

 

Previous Article
Project Management Lead for Medical Evidence, Research, and Innovation Team
Project Management Lead for Medical Evidence, Research, and Innovation Team

An F500 biotech company wanted to engage a consultant to work with its medical evidence, research, and inno...

Next Article
Managing Patient / HCP Promotions Process in Biopharma
Managing Patient / HCP Promotions Process in Biopharma

The U.S. patient access team at an F200 biopharma leader was seeking a strong project manager who would sup...